Patient was educated on Dabigatran and its mechanism of action as follows:

1. Dabigatran is an anticoagulant inhibiting some proteins that help clotting.
2. Dabigatran inhibits the thrombin factor along the coagulation pathway.
3. Dabigatran helps individuals with atrial fibrillation, by preventing formation of clot and consequent stroke.
4. Inhibition of clot formation also offers protection against deep venous thrombosis, consequent development of pulmonary embolism and episodes of myocardial infarction and chest pain.
5. So, Dabigatran is widely used in individuals undergoing hip and knee surgeries and other procedures that involve prolonged immobilization and a high risk for prolonged development of deep venous thrombosis.